Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2014

01-12-2014 | Original Article

Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis

Authors: G. Tian, J.-N. Liang, H.-F. Pan, D. Zhou

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2014

Login to get access

Abstract

Aim

Published data regarding the association of leptin levels with rheumatoid arthritis (RA) are contradictory. To derive a more precise estimation of this relationship, a meta-analysis was performed.

Methods

Published literature from PubMed, Embase and Cochrane Library was obtained. Pooled standard mean difference (SMD) with 95 % confidence interval (CI) was calculated using fixed-effects or random-effect model analysis. Heterogeneity among studies was evaluated using the Cochran Q and I 2 statistics. The study quality was assessed by the Newcastle–Ottawa scale.

Results

A total of 20 studies including 998 RA patients and 692 controls were finally included in the meta-analysis. Compared to healthy controls, RA patients had significantly higher leptin levels (SMD 1.19, 95 % CI 0.59–1.79). Subgroup analyses showed that region, race, age, body mass index (BMI), disease duration and disease activity were positively associated with plasma leptin levels in RA patients. Sensitivity analysis showed no significant change when any one study was excluded. Publication bias was also undetected.

Conclusions

The present meta-analysis suggested that leptin levels were higher in RA patients than those in healthy controls, which may be subject to different region, race, age, BMI, disease duration and disease activity.
Literature
1.
go back to reference Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2004) Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 50(11):3450–3457PubMedCrossRef Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2004) Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 50(11):3450–3457PubMedCrossRef
2.
go back to reference Naranjo A, Sokka T, Descalzo MA, Calvo-Alen J, Horslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G et al (2008) Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10(2):R30PubMedCrossRefPubMedCentral Naranjo A, Sokka T, Descalzo MA, Calvo-Alen J, Horslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G et al (2008) Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10(2):R30PubMedCrossRefPubMedCentral
3.
go back to reference Shimizu H, Shimomura K, Negishi M, Masunaga M, Uehara Y, Sato N, Shimomura Y, Kasai K, Mori M (2002) Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition 18(4):309–312PubMedCrossRef Shimizu H, Shimomura K, Negishi M, Masunaga M, Uehara Y, Sato N, Shimomura Y, Kasai K, Mori M (2002) Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition 18(4):309–312PubMedCrossRef
4.
go back to reference Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295PubMedCrossRef Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295PubMedCrossRef
5.
go back to reference Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gomez-Reino JJ, Gualillo O (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579(2):295–301PubMedCrossRef Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gomez-Reino JJ, Gualillo O (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579(2):295–301PubMedCrossRef
6.
go back to reference Hultgren OH, Tarkowski A (2001) Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res 3(6):389–394PubMedCrossRefPubMedCentral Hultgren OH, Tarkowski A (2001) Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res 3(6):389–394PubMedCrossRefPubMedCentral
7.
go back to reference Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis ? Rheumatol Int 27(4):335–338PubMedCrossRef Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis ? Rheumatol Int 27(4):335–338PubMedCrossRef
8.
go back to reference Anders HJ, Rihl M, Heufelder A, Loch O, Schattenkirchner M (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48(6):745–748PubMedCrossRef Anders HJ, Rihl M, Heufelder A, Loch O, Schattenkirchner M (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48(6):745–748PubMedCrossRef
9.
go back to reference Kopec-Medrek M, Kotulska A, Widuchowska M, Adamczak M, Wiecek A, Kucharz EJ (2012) Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-alpha antagonist. Rheumatol Int 32(11):3383–3389PubMedCrossRefPubMedCentral Kopec-Medrek M, Kotulska A, Widuchowska M, Adamczak M, Wiecek A, Kucharz EJ (2012) Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-alpha antagonist. Rheumatol Int 32(11):3383–3389PubMedCrossRefPubMedCentral
10.
go back to reference Tokarczyk-Knapik A, Nowicki M, Wyroslak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn 108(2):761–767PubMed Tokarczyk-Knapik A, Nowicki M, Wyroslak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn 108(2):761–767PubMed
11.
go back to reference Harle P, Pongratz G, Weidler C, Buttner R, Scholmerich J, Straub RH (2004) Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 63(7):809–816PubMedCrossRefPubMedCentral Harle P, Pongratz G, Weidler C, Buttner R, Scholmerich J, Straub RH (2004) Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 63(7):809–816PubMedCrossRefPubMedCentral
12.
go back to reference Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62(10):952–956PubMedCrossRefPubMedCentral Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62(10):952–956PubMedCrossRefPubMedCentral
13.
go back to reference Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cedoz JP, Wendling D (2005) Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology 44(1):120–125PubMedCrossRef Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cedoz JP, Wendling D (2005) Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology 44(1):120–125PubMedCrossRef
14.
go back to reference Salazar-Paramo M, Gonzalez-Ortiz M, Gonzalez-Lopez L, Sanchez-Ortiz A, Valera-Gonzalez IC, Martinez-Abundis E, Balcazar-Munoz BR, Garcia-Gonzalez A, Gamez-Nava JI (2001) Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol 7(1):57–59PubMedCrossRef Salazar-Paramo M, Gonzalez-Ortiz M, Gonzalez-Lopez L, Sanchez-Ortiz A, Valera-Gonzalez IC, Martinez-Abundis E, Balcazar-Munoz BR, Garcia-Gonzalez A, Gamez-Nava JI (2001) Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol 7(1):57–59PubMedCrossRef
15.
go back to reference Allam A, Radwan A (2012) The relationship of serum leptin levels with disease activity in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 34(4):185–190CrossRef Allam A, Radwan A (2012) The relationship of serum leptin levels with disease activity in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 34(4):185–190CrossRef
16.
go back to reference Yoshino T, Kusunoki N, Tanaka N, Kaneko K, Kusunoki Y, Endo H, Hasunuma T, Kawai S (2011) Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med 50(4):269–275PubMedCrossRef Yoshino T, Kusunoki N, Tanaka N, Kaneko K, Kusunoki Y, Endo H, Hasunuma T, Kawai S (2011) Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med 50(4):269–275PubMedCrossRef
17.
go back to reference El-Batch MM, Zakaria SS, Farouk G, El Saadany H, Selim M (2010) Changes in visfatin, adiponectin, leptin and ghrelin levels in patients with rheumatoid arthritis and their correlation with disease activity. Turk J Biochem 35(1):50–57 El-Batch MM, Zakaria SS, Farouk G, El Saadany H, Selim M (2010) Changes in visfatin, adiponectin, leptin and ghrelin levels in patients with rheumatoid arthritis and their correlation with disease activity. Turk J Biochem 35(1):50–57
18.
go back to reference Ismail F, Ali HAH, Ibrahim HM (2011) Possible role of leptin, and tumor necrosis factor-alpha in hypoandrogenicity in patients with early rheumatoid arthritis. Egypt Rheumatol 33(4):209–215CrossRef Ismail F, Ali HAH, Ibrahim HM (2011) Possible role of leptin, and tumor necrosis factor-alpha in hypoandrogenicity in patients with early rheumatoid arthritis. Egypt Rheumatol 33(4):209–215CrossRef
19.
go back to reference Olama SM, Senna MK, Elarman M (2012) Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int 32(3):683–690PubMedCrossRef Olama SM, Senna MK, Elarman M (2012) Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int 32(3):683–690PubMedCrossRef
20.
go back to reference Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60(7):1906–1914PubMedCrossRefPubMedCentral Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60(7):1906–1914PubMedCrossRefPubMedCentral
21.
go back to reference Seven A, Guzel S, Aslan M, Hamuryudan V (2009) Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int 29(7):743–747PubMedCrossRef Seven A, Guzel S, Aslan M, Hamuryudan V (2009) Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int 29(7):743–747PubMedCrossRef
22.
go back to reference Elwakkad AS, Said RN, Muhammad SI, Saleh MT, Elhamshary A (2007) Role for leptin and prolactin in human juvenile rheumatic diseases. Pak J Biol Sci 10(12):1984–1989PubMedCrossRef Elwakkad AS, Said RN, Muhammad SI, Saleh MT, Elhamshary A (2007) Role for leptin and prolactin in human juvenile rheumatic diseases. Pak J Biol Sci 10(12):1984–1989PubMedCrossRef
23.
go back to reference Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 99(10):1078–1083PubMedCrossRef Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 99(10):1078–1083PubMedCrossRef
24.
go back to reference Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8):1195–1198PubMedCrossRefPubMedCentral Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8):1195–1198PubMedCrossRefPubMedCentral
25.
go back to reference Nishiya K, Nishiyama M, Chang A, Shinto A, Hashimoto K (2002) Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index. Rinsho Byori Jpn J Clin Pathol 50(5):524–527 Nishiya K, Nishiyama M, Chang A, Shinto A, Hashimoto K (2002) Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index. Rinsho Byori Jpn J Clin Pathol 50(5):524–527
26.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA J Am Med Assoc 283(15):2008–2012CrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA J Am Med Assoc 283(15):2008–2012CrossRef
27.
go back to reference Wells G, Shea B, O’Connell D, Peterson J, Welch V (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control studies in meta-analyses. Eur J Epidemiol 25(9):603–605 Wells G, Shea B, O’Connell D, Peterson J, Welch V (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control studies in meta-analyses. Eur J Epidemiol 25(9):603–605
28.
go back to reference Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, Teoh KH (2008) Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J 29(21):2592–2600PubMedCrossRef Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, Teoh KH (2008) Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J 29(21):2592–2600PubMedCrossRef
29.
go back to reference Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129CrossRef Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129CrossRef
30.
go back to reference Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef
32.
go back to reference Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1198–1201PubMedCrossRefPubMedCentral Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1198–1201PubMedCrossRefPubMedCentral
33.
go back to reference Targonska-Stepniak B, Majdan M, Dryglewska M (2008) Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int 28(6):585–591PubMedCrossRef Targonska-Stepniak B, Majdan M, Dryglewska M (2008) Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int 28(6):585–591PubMedCrossRef
34.
go back to reference Sugioka Y, Tada M, Okano T, Nakamura H, Koike T (2012) Acquired leptin resistance by high-fat feeding reduces inflammation from collagen antibody-induced arthritis in mice. Clin Exp Rheumatol 30(5):707–713PubMed Sugioka Y, Tada M, Okano T, Nakamura H, Koike T (2012) Acquired leptin resistance by high-fat feeding reduces inflammation from collagen antibody-induced arthritis in mice. Clin Exp Rheumatol 30(5):707–713PubMed
35.
go back to reference Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P (2009) Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. J Rheumatol 36(4):724–730PubMedCrossRef Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P (2009) Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. J Rheumatol 36(4):724–730PubMedCrossRef
36.
go back to reference Ruhl CE, Everhart JE (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17(10):1896–1903PubMedCrossRef Ruhl CE, Everhart JE (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17(10):1896–1903PubMedCrossRef
Metadata
Title
Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis
Authors
G. Tian
J.-N. Liang
H.-F. Pan
D. Zhou
Publication date
01-12-2014
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2014
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1072-9

Other articles of this Issue 4/2014

Irish Journal of Medical Science (1971 -) 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.